Product Information
RAMIPRIL 10 MG CAPSULE is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.0743 per EA under NDC 68180059109. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Jun 9, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the Ramipril market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180059109
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
RAMIPRILApproval Type
Generic (ANDA)
FDA Application
ANDA077626FDA Approved
6/9/2008
TE Code
AB
On Market Since
6/10/2008
Pharmacological Classes
Price Statistics
The NADAC for RAMIPRIL 10 MG CAPSULE has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 23.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0743 per EA |
|---|---|
| All-time high | $0.1118 (Mar 12, 2014) |
| All-time low | $0.0475 (Nov 20, 2024) |
| 52-week high | $0.0750 |
| 52-week low | $0.0700 |
| Median price | $0.0729 |
| Average price | $0.0770 |
| Largest weekly change | -25.3% (Nov 20, 2024) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RAMIPRIL 10 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RAMIPRIL 10 MG CAPSULE, manufactured by Lupin Pharmaceuticals Inc., is $0.0743 per EA (NDC 68180059109), effective Aug 19, 2026.
How has the price of RAMIPRIL 10 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RAMIPRIL 10 MG CAPSULE has declined 23.5%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for RAMIPRIL 10 MG CAPSULE?
Since Nov 28, 2013, the NADAC for RAMIPRIL 10 MG CAPSULE has ranged from a low of $0.0475 (Nov 20, 2024) to a high of $0.1118 (Mar 12, 2014), with a median of $0.0729 per EA.
Are there cheaper alternatives to RAMIPRIL 10 MG CAPSULE?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RAMIPRIL 10 MG CAPSULE, is $0.0694 per EA — about 7% below RAMIPRIL 10 MG CAPSULE.
Who manufactures RAMIPRIL 10 MG CAPSULE?
RAMIPRIL 10 MG CAPSULE (NDC 68180059109) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.